Service/Supplier
Filter News
Found 30,372 articles
-
Clinical Pilot Study Confirms the Accuracy and Effectiveness of Pixee Medical's Knee+ Solution Using Vuzix M400 Smart Glasses for Total Knee Arthroplasty
9/17/2021
Vuzix® Corporation, a leading supplier of Smart Glasses and Augmented Reality technology and products, announced that the Vuzix M400 Smart Glasses were recently featured in a clinical pilot study that examined the accuracy of the Pixee Medical Knee + augmented reality navigation in performing Total Knee Arthroplasty.
-
Median Technologies Has Been Confirmed as a Preferred Vendor by one of the Top 3 Pharmaceutical Companies in the World, and Selected to Implement Their Clinical Trial Imaging Strategy on Some Key Oncology Indications
9/16/2021
Median Technologies (Paris:ALMDT) (ALMDT:PA) announced today that the company has been confirmed as a preferred vendor by one of the Top 3 pharmaceutical companies in the world and selected to implement their clinical trial imaging strategy on some key oncology indications.
-
Ohio State University Wexner Medical Center Receives Ohio's First Hyperfine Portable MRI Systems to Speed Scanning and Diagnosis for Urgent Brain Injuries
9/16/2021
Hyperfine, Inc. is proud to announce that The Ohio State University Wexner Medical Center is deploying two Swoop™ systems in the emergency room, and the Comprehensive Stroke Center operating room.
-
Genesis Drug Discovery & Development Appoints Anthony Rohr as Chief Operating Officer
9/16/2021
Genesis Drug Discovery & Development, the contract research organization arm of Genesis Biotechnology Group®, has announced the appointment of Anthony Rohr, current Chief Executive Officer of PharmOptima, as its new Chief Operating Officer.
-
Automated Enzyme Analyzers Streamline Enzyme Assay Applications
9/16/2021
Multi-enzyme analysis can now be achieved through a single, fully-automated enzyme analyzer, benefitting industrial enzyme manufacturers and enzyme users in the food, beverage, biopharmaceutical, fuel ethanol and chemical, and solid waste management industries.
-
BWXT Medical and Bayer AG Enter into Agreement for the Development and Production of Actinium-225
9/16/2021
BWX Technologies, Inc. announced that its BWXT Medical Ltd. subsidiary has entered into an agreement with Bayer AG to develop Actinium-225 supply and further partnering opportunities on finished products as both companies broaden their respective commercialization strategies for targeted radionuclide therapies and other innovative products.
-
Argenta Acquires Top Clinical Research Organization Klifovet to Enhance Services and Expand Global Footprint
9/16/2021
Argenta, the only combined global contract research organization and contract development & manufacturing organization dedicated to animal health, announced that it has acquired Klifovet, the leading CRO and Regulatory Affairs consultancy organization in Europe.
-
Mannkind Corporation Participating at Upcoming Conferences - Sep 15, 2021
9/15/2021
MannKind Corporation, a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced that it will be participating at upcoming conferences.
-
Sensorion And Hearing Care Leader Sonova Sign Strategic Research Collaboration
9/15/2021
Sensorion and Sonova, have signed a multi-year strategic collaboration with the aim of introducing genetic analysis to the routine diagnosis of progressive hearing loss in adults, thereby opening the way for improved care through a combination of advanced therapeutic interventions and traditional hearing aids.
-
iPharma Inhalation Labs Now Supporting GMP Drug/Device Release Testing for Pulmonary Clinical Phase 1 & 2 Studies
9/15/2021
iPharma Labs, Inc., a privately-held contract development research organization specializing in inhalation pharmaceutical development services, announced the implementation of GMP services for release testing for inhalation clinical trials.
-
Guardant Health Showcases Data at ESMO 2021 Demonstrating Utility of Guardant360® Liquid Biopsy to Obtain Comprehensive Molecular Information to Guide Targeted Therapy Options for Late-Stage Cancers
9/15/2021
Guardant Health, Inc., along with leading academic institutions and pharmaceutical companies, share data highlighting molecular targets of importance, treatment resistance patterns, and advantages of using the Guardant360® liquid biopsy test to help improve the management of advanced solid cancers at the European Society for Medical Oncology 2021 virtual congress on September 16-21.
-
Echosens Underscores Impact of Obesity in Nonalcoholic Fatty Liver Disease & Metabolic Syndrome, Emphasizes Role of FibroScan to Monitor Liver Stiffness and Fat at Point-of-Care
9/15/2021
Echosens announces the release of its white paper, “Early Detection, Healthy Diet and Lifestyle Changes Critical for Addressing Metabolic Syndrome and Halting Progression of Liver Disease,” authored by Dr. Juan Pablo Frias, M.D., medical director and principal investigator, National Research Institute, Los Angeles.
-
Caris Life Sciences to Present New Data at ESMO 2021 Highlighting Gene Expression in Colorectal Cancer - Comprehensive Profiling and Clinical Value
9/15/2021
Caris Life Sciences® announced results from a study highlighting a strong association between CCR5/CCL5 gene expression and distinct molecular features including Consensus Molecular Subtype, tumor mutational burden, lymphocyte infiltration in the tumor microenvironment, as well as patient outcome, and treatment benefit in Colorectal Cancer.
-
Hearing Restoration For The Deaf: Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL
9/15/2021
Blackrock Neurotech, a leading provider of brain computer interface technology for human patients, has announced plans to invest in a novel auditory nerve implant device that restores hearing for the deaf.
-
Several life sciences companies were sprinkled throughout this year's list. Here's a look at a few of the honorees.
-
Concert Genetics Publishes Complete Genetic Testing Reference Policies Integrated with Open, Searchable Test Catalog
9/14/2021
Concert Genetics has released a complete set of medical policies integrated with its catalog of more than 160,000 genetic testing products.
-
Seqens Appoints Bob Huang Managing Director of North American CDMO Operations
9/14/2021
Seqens CDMO North America today announced that Bob Huang has joined as Managing Director for North America.
-
Reminder: Centene Corporation's 2021 Third Quarter Financial Results Conference Call
9/14/2021
Centene Corporation issued a reminder that it will release its 2021 third quarter financial results at approximately 6 a.m. on Tuesday, October 26, 2021, and host a conference call afterwards at approximately 8:30 a.m. to review the results.
-
Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.
9/14/2021
Mesa Laboratories, Inc., a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, and medical device industries, announced that it has entered into a definitive agreement to acquire Agena Bioscience, Inc. for a cash purchase price of $300 million, subject to customary purchase price adjustments.
-
Biognosys Enters Collaboration with Leading Life Science Company to Advance Next-generation Proteomics
9/14/2021
Biognosys, an innovator and leader in next-generation proteomics technology and solutions for life sciences research, announced that they have entered a collaboration with Evotec, a life science company that discovers, develops, and provides highly effective therapeutics for patients, to advance the adoption of next-generation proteomics in drug discovery and clinical research.